Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197743 · ClinicalTrials.gov registry record · Phase 3
Trial of Vitamins in HIV Progression and Transmission
A Phase 3 study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- Phase 3
- Development phase
- 1,085
- Enrollment target
NCT00197743: Completed Phase 3 study, sponsored by Harvard School of Public Health (HSPH).
NCT00197743 is a Phase 3 study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 1,085 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (41% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00197743, a Phase 3 study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,085 participants
- Enrollment target
Study Summary
This study tested the hypothesis that multivitamin supplementation given to HIV+ pregnant women in Tanzania would slow disease progression and enhance their overall health.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Multivitamins
- DIETARY_SUPPLEMENT Vitamin A + Beta Carotene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,085 participants |
| Start Date | 1995-04 |
| Est. Completion | 2003-08 |
| Phase | Phase 3 |
What the finished NCT00197743 record still lists
NCT00197743 is an interventional study that assigns participants to a tested intervention. Its 1,085 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (41% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00197743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00197743 about?
NCT00197743 is a clinical study titled "Trial of Vitamins in HIV Progression and Transmission". This study tested the hypothesis that multivitamin supplementation given to HIV+ pregnant women in Tanzania would slow disease progression and enhance their overall health.
What is the current status of trial NCT00197743?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,085 participants. The study started on 1995-04. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00197743?
The interventions under investigation include: Placebo (OTHER), Multivitamins (DIETARY_SUPPLEMENT), Vitamin A + Beta Carotene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00197743?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00197743's enrollment target sits among peer trials
1,085 269th of 2000 higher than 1,732 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06671483 · 1,088 participants · Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
- NCT07196722 · 1,092 participants · Phase 2
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia